Closed-loop control systems – The quest for precision therapies for diabetes

Ben-Othman, 2017, Long-term GABA administration induces alpha cell-mediated beta-like cell neogenesis, Cell, 168, 73, 10.1016/j.cell.2016.11.002 Nair, 2015, Islet formation in mice and men: lessons for the generation of functional insulin-producing beta-cells from human pluripotent stem cells, Curr Opin Genet Dev, 32, 171, 10.1016/j.gde.2015.03.004 Farhy, 2010, Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action, J Diabetes Sci Technol, 4, 1345, 10.1177/193229681000400608 Kieffer, 2016, Closing in on mass production of mature human beta cells, Cell Stem Cell, 18, 699, 10.1016/j.stem.2016.05.014 Drucker, 2006, The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes, Lancet, 368, 1696, 10.1016/S0140-6736(06)69705-5 Ashcroft, 2013, K(ATP) channels and islet hormone secretion: new insights and controversies, Nat Rev Endocrinol, 9, 660, 10.1038/nrendo.2013.166 Chambers, 2017, The role of pancreatic preproglucagon in glucose homeostasis in mice, Cell Metab, 25, 927, 10.1016/j.cmet.2017.02.008 Habener, 2017, Pancreas and not gut mediates the GLP-1-induced glucoincretin effect, Cell Metab, 25, 757, 10.1016/j.cmet.2017.03.020 Johnson, 2013, The origins and drivers of insulin resistance, Cell, 152, 673, 10.1016/j.cell.2013.01.041 Bailey, 2016, Future glucose-lowering drugs for type 2 diabetes, Lancet Diabetes Endocrinol, 4, 350, 10.1016/S2213-8587(15)00462-3 Guy, 2016, Diagnostic devices: managing diabetes through the skin, Nat Nanotechnol, 11, 493, 10.1038/nnano.2016.53 Pickup, 2012, Insulin-pump therapy for type 1 diabetes mellitus, N Engl J Med, 366, 1616, 10.1056/NEJMct1113948 Vashist, 2015, Emerging technologies for next-generation point-of-care testing, Trends Biotechnol, 33, 692, 10.1016/j.tibtech.2015.09.001 Ang, 2015, Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas, Expert Opin Drug Deliv, 12, 1579, 10.1517/17425247.2015.1074174 Smalley, 2016, Medtronic automated insulin delivery device gets FDA nod, Nat Biotechnol, 34, 1220, 10.1038/nbt1216-1220 Forlenza, 2016, Progress in diabetes technology: developments in insulin pumps, continuous glucose monitors, and progress towards the artificial pancreas, J Pediatr, 169, 13, 10.1016/j.jpeds.2015.10.015 Trevitt, 2016, Artificial pancreas device systems for the closed-loop control of type 1 diabetes: what systems are in development?, J Diabetes Sci Technol, 10, 714, 10.1177/1932296815617968 Dolgin, 2016, Diabetes: encapsulating the problem, Nature, 540, S60, 10.1038/540S60a Russell, 2014, Outpatient glycemic control with a bionic pancreas in type 1 diabetes, N Engl J Med, 371, 313, 10.1056/NEJMoa1314474 Cengiz, 2016, Moving toward the ideal insulin for insulin pumps, Expert Rev Med Devices, 13, 57, 10.1586/17434440.2016.1109442 Lee, 2016, A graphene-based electrochemical device with thermoresponsive microneedles for diabetes monitoring and therapy, Nat Nanotechnol, 11, 566, 10.1038/nnano.2016.38 Holmes, 2016, Innovation: sweat-sensing patch for glucose monitoring and drug delivery, Nat Rev Endocrinol, 12, 247, 10.1038/nrendo.2016.56 Zaykov, 2016, Pursuit of a perfect insulin, Nat Rev Drug Discov, 15, 425, 10.1038/nrd.2015.36 Ariyachet, 2016, Reprogrammed stomach tissue as a renewable source of functional beta cells for blood glucose regulation, Cell Stem Cell, 18, 410, 10.1016/j.stem.2016.01.003 Shapiro, 2017, Clinical pancreatic islet transplantation, Nat Rev Endocrinol, 13, 268, 10.1038/nrendo.2016.178 Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 Yamaguchi, 2017, Interspecies organogenesis generates autologous functional islets, Nature, 542, 191, 10.1038/nature21070 Rashid, 2014, Revisiting the flight of Icarus: making human organs from PSCs with large animal chimeras, Cell Stem Cell, 15, 406, 10.1016/j.stem.2014.09.013 Cerda-Esteban, 2017, Stepwise reprogramming of liver cells to a pancreas progenitor state by the transcriptional regulator Tgif2, Nat Commun, 8, 14127, 10.1038/ncomms14127 Rostovskaya, 2015, Towards consistent generation of pancreatic lineage progenitors from human pluripotent stem cells, Philos Trans R Soc Lond B Biol Sci, 370, 20140365, 10.1098/rstb.2014.0365 Vierbuchen, 2011, Direct lineage conversions: unnatural but useful?, Nat Biotechnol, 29, 892, 10.1038/nbt.1946 Chakravarthy, 2017, Converting adult pancreatic islet alpha cells into beta cells by targeting both Dnmt1 and Arx, Cell Metab, 25, 622, 10.1016/j.cmet.2017.01.009 Li, 2017, Artemisinins target GABAA receptor signaling and impair alpha cell identity, Cell, 168, 86, 10.1016/j.cell.2016.11.010 Cheng, 2017, Fasting-mimicking diet promotes Ngn3-driven beta-cell regeneration to reverse diabetes, Cell, 168, 775, 10.1016/j.cell.2017.01.040 Li, 2014, Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells, Nat Biotechnol, 32, 1223, 10.1038/nbt.3082 Mount, 2015, Cell-based therapy technology classifications and translational challenges, Philos Trans R Soc Lond B Biol Sci, 370, 20150017, 10.1098/rstb.2015.0017 Soria, 2016, A role for the host in the roadmap to diabetes stem cell therapy, Diabetes, 65, 1155, 10.2337/dbi16-0003 Teague, 2016, Synthetic morphogenesis, Cold Spring Harb Perspect Biol, 8 Nostro, 2015, Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines, Stem Cell Rep, 4, 591, 10.1016/j.stemcr.2015.02.017 Agulnick, 2015, Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices, In Vivo Stem Cells Transl Med, 4, 1214, 10.5966/sctm.2015-0079 Zhu, 2016, Human pancreatic beta-like cells converted from fibroblasts, Nat Commun, 7, 10080, 10.1038/ncomms10080 Pagliuca, 2014, Generation of functional human pancreatic beta cells in vitro, Cell, 159, 428, 10.1016/j.cell.2014.09.040 Rezania, 2014, Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells, Nat Biotechnol, 32, 1121, 10.1038/nbt.3033 Saxena, 2016, A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells, Nat Commun, 7, 11247, 10.1038/ncomms11247 Unger, 2008, Good manufacturing practice and clinical-grade human embryonic stem cell lines, Hum Mol Genet, 17, R48, 10.1093/hmg/ddn079 Xie, 2016, beta-cell-mimetic designer cells provide closed-loop glycemic control, Science, 354, 1296, 10.1126/science.aaf4006 Auslander, 2014, A synthetic multifunctional mammalian pH sensor and CO2 transgene-control device, Mol Cell, 55, 397, 10.1016/j.molcel.2014.06.007 Xue, 2017, A synthetic-biology-inspired therapeutic strategy for targeting and treating hepatogenous diabetes, Mol Ther, 25, 443, 10.1016/j.ymthe.2016.11.008 Ye, 2016, Self-adjusting synthetic gene circuit for correcting insulin resistance, Nat Biomed Eng, 1, 1, 10.1038/s41551-016-0005 Samuel, 2012, Mechanisms for insulin resistance: common threads and missing links, Cell, 148, 852, 10.1016/j.cell.2012.02.017 Weyer, 2001, Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia, J Clin Endocrinol Metab, 86, 1930, 10.1210/jcem.86.5.7463 Prentki, 2006, Islet beta cell failure in type 2 diabetes, J Clin Investig, 116, 1802, 10.1172/JCI29103 Rössger, 2013, A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice, Nat Commun, 4, 2825, 10.1038/ncomms3825 Bai, 2016, A synthetic biology-based device prevents liver injury in mice, J Hepatol, 65, 84, 10.1016/j.jhep.2016.03.020 Haellman, 2016, Synthetic biology-toward therapeutic solutions, J Mol Biol, 428, 945, 10.1016/j.jmb.2015.08.020 Ye, 2014, Synthetic therapeutic gene circuits in mammalian cells, FEBS Lett, 588, 2537, 10.1016/j.febslet.2014.05.003